BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29568887)

  • 1. Genome-wide analysis of DNA methylation in human peripheral leukocytes identifies potential biomarkers of nonalcoholic fatty liver disease.
    Zhang RN; Pan Q; Zheng RD; Mi YQ; Shen F; Zhou D; Chen GY; Zhu CY; Fan JG
    Int J Mol Med; 2018 Jul; 42(1):443-452. PubMed ID: 29568887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered DNA Methylation Sites in Peripheral Blood Leukocytes from Patients with Simple Steatosis and Nonalcoholic Steatohepatitis (NASH).
    Wu J; Zhang R; Shen F; Yang R; Zhou D; Cao H; Chen G; Pan Q; Fan J
    Med Sci Monit; 2018 Oct; 24():6946-6967. PubMed ID: 30270343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways.
    Gerhard GS; Malenica I; Llaci L; Chu X; Petrick AT; Still CD; DiStefano JK
    Clin Epigenetics; 2018 Jul; 10(1):93. PubMed ID: 30005700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.
    Murphy SK; Yang H; Moylan CA; Pang H; Dellinger A; Abdelmalek MF; Garrett ME; Ashley-Koch A; Suzuki A; Tillmann HL; Hauser MA; Diehl AM
    Gastroenterology; 2013 Nov; 145(5):1076-87. PubMed ID: 23916847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide DNA methylation profiling in nonalcoholic fatty liver reveals predictive aberrant methylation in PRKCE and SEC14L3 promoters.
    Pan X; Wu Y; Peng H; Cai X; Hu Z; Lin X; Peng XE
    Dig Liver Dis; 2022 Apr; 54(4):521-528. PubMed ID: 34108094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Methylation in Nonalcoholic Fatty Liver Disease.
    Hyun J; Jung Y
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
    Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
    World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease.
    Nishida N; Yada N; Hagiwara S; Sakurai T; Kitano M; Kudo M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1646-53. PubMed ID: 26875698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease.
    Hardy T; Zeybel M; Day CP; Dipper C; Masson S; McPherson S; Henderson E; Tiniakos D; White S; French J; Mann DA; Anstee QM; Mann J
    Gut; 2017 Jul; 66(7):1321-1328. PubMed ID: 27002005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAFLD is associated with methylation shifts with relevance for the expression of genes involved in lipoprotein particle composition.
    Mwinyi J; Boström AE; Pisanu C; Murphy SK; Erhart W; Schafmayer C; Hampe J; Moylan C; Schiöth HB
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Mar; 1862(3):314-323. PubMed ID: 27993651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease.
    Kitamoto T; Kitamoto A; Ogawa Y; Honda Y; Imajo K; Saito S; Yoneda M; Nakamura T; Nakajima A; Hotta K
    J Hepatol; 2015 Aug; 63(2):494-502. PubMed ID: 25776890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease.
    Hendy OM; Elsabaawy MM; Aref MM; Khalaf FM; Oda AMA; El Shazly HM
    APMIS; 2017 Jul; 125(7):607-613. PubMed ID: 28430371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease.
    Xu Q; Li Y; Shang YF; Wang HL; Yao MX
    World J Gastroenterol; 2015 Jan; 21(2):511-6. PubMed ID: 25593466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic steatohepatitis is associated with a state of betaine-insufficiency.
    Sookoian S; Puri P; Castaño GO; Scian R; Mirshahi F; Sanyal AJ; Pirola CJ
    Liver Int; 2017 Apr; 37(4):611-619. PubMed ID: 27614103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A targeted analysis reveals relevant shifts in the methylation and transcription of genes responsible for bile acid homeostasis and drug metabolism in non-alcoholic fatty liver disease.
    Schiöth HB; Boström A; Murphy SK; Erhart W; Hampe J; Moylan C; Mwinyi J
    BMC Genomics; 2016 Jun; 17():462. PubMed ID: 27301979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
    Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis.
    Arulanandan A; Ang B; Bettencourt R; Hooker J; Behling C; Lin GY; Valasek MA; Ix JH; Schnabl B; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1513-20.e1. PubMed ID: 25661453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease.
    Pirola CJ; Gianotti TF; Burgueño AL; Rey-Funes M; Loidl CF; Mallardi P; Martino JS; Castaño GO; Sookoian S
    Gut; 2013 Sep; 62(9):1356-63. PubMed ID: 22879518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease.
    Dong S; Zhan ZY; Cao HY; Wu C; Bian YQ; Li JY; Cheng GH; Liu P; Sun MY
    World J Gastroenterol; 2017 Apr; 23(15):2771-2784. PubMed ID: 28487615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
    World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.